Selecting The Selectors

The advice recently given to aspiring authors (T.W. Durso, "Editors' Advice To Rejected Authors: Just Try, Try Again," The Scientist, Sept. 15, 1997, page 13) fosters an imperfect status quo. It fails to address those really troublesome problems that are particularly the bane of any newcomer to a field. Intentionally or not, Durso's article puts the onus subtly but firmly on authors to meet publishers' criteria, as though there are well-defined standards that may be met reliably by careful comp

Written byMalcolm Atkinson
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The advice recently given to aspiring authors (T.W. Durso, "Editors' Advice To Rejected Authors: Just Try, Try Again," The Scientist, Sept. 15, 1997, page 13) fosters an imperfect status quo. It fails to address those really troublesome problems that are particularly the bane of any newcomer to a field. Intentionally or not, Durso's article puts the onus subtly but firmly on authors to meet publishers' criteria, as though there are well-defined standards that may be met reliably by careful composition. But these putative standards are ill-defined, and restrictions on publishing are imposed without appropriate scientific methodology.

Although it is important to encourage clear, concise, and persuasive writing, the more intractable problem has proved to be the incalculable constraint on communication of largely untested and often irrational criticism, and consequently of whimsical selection. Failings of the peer-review system are all too often exacerbated by the frustration of unconscionable delay. There is ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies